Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients
Public ClinicalTrials.gov record NCT05255445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients (RBC-IMPACT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused recipients (RBC-IMPACT) is an observational cohort study to assess donor, component, and recipient factors that contribute to RBC efficacy in chronically and episodically transfused patients. The objective of the study is to determine how specific genetic and non-genetic factors in donors and recipients may impact RBC survival after transfusion - in short, what factors on both the donor and recipient side may improve the efficacy of the transfusion.
Study identification
- NCT ID
- NCT05255445
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2022 (Actual)
- Primary completion
- Mar 31, 2024 (Actual)
- Completion
- Mar 31, 2024 (Actual)
- Last update posted
- May 17, 2024
2022 – 2024
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF Benioff Children's Hospital | Oakland | California | 94609 | — |
| Vitalant Research Institute | San Francisco | California | 94118 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| Weill Cornell Medical Collection (WCMC)/New York Presbyterian Hospital (NYPH) | New York | New York | 10021 | — |
| Columbia University Irving Medical Center/New York Presbyterian Hospital (NYPH) | New York | New York | 10032 | — |
| New York Blood Center (NYBC) | New York | New York | 10065 | — |
| Children's Wisconsin | Milwaukee | Wisconsin | 53226 | — |
| Froedtert Hospital | Milwaukee | Wisconsin | 53226 | — |
| Versiti Wisconsin, Inc. | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05255445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05255445 live on ClinicalTrials.gov.